v3.26.1
Document And Entity Information
Mar. 16, 2026
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 16, 2026
Entity Registrant Name CytomX Therapeutics, Inc.
Entity Central Index Key 0001501989
Entity Emerging Growth Company false
Entity File Number 001-37587
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 27-3521219
Entity Address, Address Line One 151 Oyster Point Blvd
Entity Address, Address Line Two Suite 400
Entity Address, City or Town South San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94080
City Area Code 650
Local Phone Number 515-3185
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.00001 par value per share
Trading Symbol CTMX
Security Exchange Name NASDAQ